Zhengye Biotechnology Holding Limited (ZYBT) Investment Research Dashboard
About Zhengye Biotechnology Holding Limited (ZYBT) stock analysis
Get live ZYBT stock price $2.36, comprehensive Zhengye Biotechnology Holding Limited stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time ZYBT stock data and investment insights.
Loading chart data...
Investment Score
A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Zhengye Biotechnology Holding Limited specializes in the creation, manufacturing, and commercialization of animal health immunizations. The company primarily supplies the Chinese agricultural sector with vaccines tailored for a broad spectrum of farm...
Company Information
- CEO
- Songlin Song
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 269
Contact Information
- Website
- https://www.jlzybio.com
- Address
- No.1 Lianmeng Road
- Country
- CN
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Lower volatility stock (Beta: -2.69) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Zhengye Biotechnology Holding Limited shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Zhengye Biotechnology Holding Limited
- ⚠Investors should consider how Zhengye Biotechnology Holding Limited fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
111.84M
P/E Ratio (TTM)
-10.73
Beta
-2.69
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare ZYBT with peer companies:
- Price
- $4.14-3.27% (1D)
- Market cap
- 174.34M
- Price
- $2.39+3.46% (1D)
- Market cap
- 23.84M
- Price
- $1.34-1.47% (1D)
- Market cap
- 154.46M
- Price
- $5.44+17.75% (1D)
- Market cap
- 50.49M
- Price
- $3.08+3.70% (1D)
- Market cap
- 36.85M
- Price
- $0.80-1.64% (1D)
- Market cap
- 80.01M
- Price
- $66.30-3.13% (1D)
- Market cap
- 211.68M
- Price
- $2.00+3.63% (1D)
- Market cap
- 76.38M
- Price
- $21.95-0.23% (1D)
- Market cap
- 164.13M
- Price
- $7.26+0.14% (1D)
- Market cap
- 49.24M
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
63/100 ⭐⭐⭐⭐
- Overall
- +0.4%
- NYSE
- +0.3%
- NASDAQ
- +0.5%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Financial Services | -0.3% | +2.2% | +4.2% | 19.6 | 93/100⭐⭐⭐⭐⭐ |
| Communication Services | -2.4% | +2.2% | +3.9% | 21.2 | 79/100⭐⭐⭐⭐⭐ |
| Healthcare | +0.4% | +0.3% | -0.7% | 23.1 | 63/100⭐⭐⭐⭐ |
| Basic Materials | +0.3% | +1.6% | -1.8% | 25.7 | 58/100⭐⭐⭐⭐ |
| Consumer Defensive | -0.8% | -1.0% | -0.3% | 29.4 | 55/100⭐⭐⭐⭐ |
| Technology | -0.9% | +3.3% | -2.0% | 44.1 | 53/100⭐⭐⭐ |
| Energy | -2.7% | +0.6% | -2.1% | 19.0 | 49/100⭐⭐⭐ |
| Consumer Cyclical | -0.5% | +1.7% | -2.4% | 44.6 | 34/100⭐⭐ |
| Industrials | -0.9% | +1.8% | -6.4% | 33.3 | 30/100⭐⭐ |
| Real Estate | -0.0% | -1.2% | -2.9% | 33.7 | 22/100⭐ |
| Utilities | -1.1% | -2.0% | -6.9% | 25.0 | 14/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-08-05.